Extended mortality results for ovarian cancer screening in the PLCO trial with median 15 years follow-up-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Extended mortality results for ovarian cancer screening in the PLCO trial with median 15 years follow-up

Published:2016-11 Issue:2 Volume:143 Page:270-275
ISSN:0090-8258
Container-title:Gynecologic Oncology
language:en
Short-container-title:Gynecologic Oncology

Author:

Pinsky Paul F.,Yu Kelly,Kramer Barnett S.,Black Amanda,Buys Saundra S.,Partridge Edward,Gohagan John,Berg Christine D.,Prorok Philip C.

Publisher

Elsevier BV

Subject

Obstetrics and Gynaecology,Oncology

Reference13 articles.

1. Effect of screening on ovarian cancer mortality. The prostate, lung, colorectal and ovarian cancer screening randomized controlled trial;Buys;JAMA,2011

2. Ovarian cancer screening and mortality in the UK collaborative trial of ovarian cancer screening (UKCTOCS): a randomized controlled trial;Jacobs;Lancet,2016

3. Ovarian cancer screening in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial: findings from the initial screen of a randomized trial;Buys;Am. J. Obstet. Gynecol.,2005

4. Changes in and impact of the death review process in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial;Miller;Rev. Recent Clin. Trials,2015

Cited by 119 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comprehensive serum glycopeptide spectra analysis to identify early-stage epithelial ovarian cancer;Scientific Reports;2024-08-28

2. Symptom-triggered testing detects early stage and low volume resectable advanced stage ovarian cancer;International Journal of Gynecologic Cancer;2024-08-13

3. Prevention of Ovarian Cancer: Where are We Now and Where are We Going?;Current Oncology Reports;2024-08-08

4. The karyometric signature is altered in fallopian tubes with serous tubal intraepithelial carcinoma;Gynecologic Oncology;2024-07

5. Deciphering the Interplay: Thieno[2,3-b]pyridine’s Impact on Glycosphingolipid Expression, Cytotoxicity, Apoptosis, and Metabolomics in Ovarian Tumor Cell Lines;International Journal of Molecular Sciences;2024-06-25

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3